{"cdcTestId":"2013-0224","testcaseName":"Dose 1 to dose 3 interval of Comvax is 16 weeks.   Series complete for Hep B. ","vaccineGroup":"HepB","evaluationTestType":"Interval: At Minimum","forecastTestType":"Not recommended: series complete","assessmentDate":"2007-02-20T00:00:00","patient":{"dob":"2006-08-08T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2006-10-31T00:00:00","vaccineName":"COMVAX","cvx":"51","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2006-12-22T00:00:00","vaccineName":"COMVAX","cvx":"51","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2007-02-20T00:00:00","vaccineName":"COMVAX","cvx":"51","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2006-10-31T00:00:00","vaccineName":"COMVAX","cvx":"51","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2006-12-22T00:00:00","vaccineName":"COMVAX","cvx":"51","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2007-02-20T00:00:00","vaccineName":"COMVAX","cvx":"51","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2018-02-26T10:30:09.947","generalDescription":"This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 16 weeks from dose #1 that the dose is considered to be valid.  The series is complete.","changedInVersion":"1.0","reasonForChange":""}